Turing Pharmaceuticals

Listing Websites about Turing Pharmaceuticals

Filter Type:

Vyera Pharmaceuticals - Wikipedia

(1 days ago) Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.
The company has two marketed products: Daraprim (pyrimethamine), for the t…

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


A Timeline of the Turing Pharma Controversy - Forbes

(8 days ago) Aug. 10 --The same day, Turing said it acquired exclusive U.S. rights to pyrimethamine (Daraprim) from Impax Laboratories . The price was $55 million. Aug. 17 —Retrophin, the company Shkreli co

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing [8 …

(7 days ago) Turing Pharmaceuticals: The Ethics of Drug Pricing change management case study solution includes John P. Kotter 8 Steps Change Management Principles. Change management process, building guiding coalition, term papers, MBA assignment help.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


‘Pharma Bro’ Martin Shkreli fined $64M, banned from …

(2 days ago) In 2015,Shkreli’s company, Turing Pharmaceuticals, acquired the rights to Daraprim, a life-saving drug that is used to treat infections that occur in patients suffering from cancer and AIDS.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


"Pharma Bro" Martin Shkreli charged with fixing price of …

(8 days ago) The FTC said Vyera, formerly Turing Pharmaceuticals, jacked up the list price of Daraprim from $17.50 a tablet to $750 each, an increase of more than 4,000%. The price hike "significantly impacted

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


‘Pharma Bro’ Martin Shkreli wins proxy battle from prison

(6 days ago) Martin Shkreli just won a proxy battle from prison. AP. It’s a remarkable feat for Shkreli who is serving a seven-year sentence through 2023 for securities fraud he committed while running two

Url: Visit Now

Category:  Health Detail Drugs


Home - Turning Point Therapeutics, Inc.

(1 days ago) The Bold. Led by Pioneers of Precision Medicine. We are medicine makers, with deep-rooted expertise in drug discovery and development. About Us. Our team is driven by a common goal – to rapidly design and develop new cancer therapies that address unmet medical needs and help make a difference in patients’ lives.

Url: Visit Now

Category:  Cancer Detail Drugs


Vyera Pharmaceuticals

(2 days ago) Vyera Pharmaceuticals is committed to developing and commercializing treatments that address serious and neglected diseases with high unmet medical needs. Read More. Research & Development. Vyera is focused on developing novel treatment options for toxoplasmosis and other rare or serious health conditions.

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Martin Shkreli - Wikipedia

(4 days ago) Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American former hedge fund manager and convicted felon. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


US pharmaceutical company defends 5,000% price increase

(9 days ago) 22 September 2015. Turing Pharmaceuticals boss Martin Shkreli had previously defended the price raise. The head of a US pharmaceutical company has defended his company's decision to raise the

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


'Pharma Bro': Turing CEO freed from prison early

(Just Now) Shkreli resigned as chief executive of Turing Pharmaceuticals — later Vyera — in 2015, a day after he was arrested on securities fraud charges. Earlier this year, he was ordered by US District

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Pharma Bro Martin Shkreli banned for life from drug industry in

(9 days ago) A federal judge ordered notorious "Pharma Bro" Martin Shkreli banned for life from the pharmaceutical industry and also ordered him to pay $64.6 million in profits he earned from hiking the price

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals CEO Martin Shkreli Arrested for Securities …

(4 days ago) — -- Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli, who was heavily criticized for raising the price of a drug used to treat a life-threatening infection by more

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Drug Goes From $13.50 a Tablet to $750, Overnight

(7 days ago) The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Working at Turing Pharmaceuticals: Employee Reviews - Indeed

(7 days ago) Turing was initially a highly dynamic and positive organization whose culture was more like a silicon valley start up than a pharma company. Also many of my co-workers where highly experienced and dynamic people. Unfortunately, things eroded quickly as our CEO became a public figure and alienated many of the constituencies in our key marketplace.

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals Launches - Drug Discovery and …

(8 days ago) Turing Pharmaceuticals AG announced its official launch, along with news of three acquisitions for its commercial operations and development pipeline. Turing’s strategic focus is to acquire and advance development of external compounds while also pursuing internal drug discovery through proprietary research and development to best address

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turning Point Therapeutics Stock Forecast, Price & News

(6 days ago) Medical Sector. 977th out of 1,436 stocks. Pharmaceutical Preparations Industry. 491st out of 687 stocks

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals - Crunchbase Company Profile & Funding

(2 days ago) Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs. The company is dedicated to helping patients, who often have no effective treatment options, by developing and commercializing innovative treatments. It was founded in 2014 and headquartered in New York, United States.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals AG LinkedIn

(5 days ago) Turing Pharmaceuticals AG is a privately-held biopharmaceutical company with offices in New York City and Zug, Switzerland. Turing focuses on …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals C.E.O.: We’ll Maybe Stop the Drug Price …

(3 days ago) As The New York Times reported on Sunday, Turing raised the price of the 62-year-old drug Daraprim to $750 a tablet from $13.50 overnight, after buying it in August. After two days of nonstop

Url: Visit Now

Category:  Health Detail Drugs


Daraprim, the $750 Pill, Finally Goes Generic - GoodRx

(Just Now) His company, Turing Pharmaceuticals, makes Daraprim, a drug that treats severe toxoplasmosis. Daraprim made headlines after its price went up by 5,000% overnight — to about $750 per tablet. Right before this, one tablet only cost $13.50. While this prompted a nationwide conversation about unaffordable drug prices, public outrage hasn’t done

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


What's New PharmaVoice

(3 days ago) Turing Pharmaceuticals, a new pharmaceutical company, launched with news of three acquisitions for its commercial operations and development pipeline. New York-based Turing is focused on developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas, for which there are

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals Careers and Employment - Indeed.com

(9 days ago) Find out what works well at Turing Pharmaceuticals from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Turing Pharmaceuticals is the best company for you.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals - STAT

(4 days ago) Turing execs warned Martin Shkreli against price hike, lawyer says. advertisement. Pharmalot By Ed Silverman. ‘Pow!’ ‘It will be huge.’. Emails show Shkreli’s team exulting at drug price

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing Harvard …

(7 days ago) In 2015 there was a public outcry over the price increase in Daraprim (pyrimethamine) by Turing Pharmaceuticals AG (Turing). Daraprim was a drug that was widely used by a small population of U.S. patients to treat toxoplasmosis. Soon after Turing acquired its commercialization rights in August 2015, the company increased the list price of the drug by …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

(7 days ago) It was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the notorious “pharma bro,” jacked up the cost of the lifesaving drug Daraprim by 5,000 percent. Overnight, its price

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals: Fair Profit or Price Gouging in the Drug

(Just Now) This case examines how a drug price increase by one small company, Turing Pharmaceuticals, became the focal point of a controversy that engulfed the entire drug industry. Turing’s decision to raise the price of its anti-infection drug Daraprim, from $13.50 to $750 per dose, is emblematic of the debate about the responsibilities of pharmaceutical companies and …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


The Dark Side of the Pharmaceutical Industry - AJMC

(Just Now) America’s disdain for the pharmaceutical industry reached fever pitch in 2015, after Turing Pharmaceuticals raised the price of its HIV treatment medication from $13.50 to a shocking $750 per

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals - Funding, Financials, Valuation & Investors

(1 days ago) Funding. Turing Pharmaceuticals has raised a total of $90M in funding over 1 round. This was a Series A round raised on Aug 10, 2015. Turing Pharmaceuticals is funded by Martin Shkreli. Turing Pharmaceuticals has a post-money valuation in the range of $100M to $500M as of Aug 10, 2016, according to PrivCo. Sign up for a free trial to view exact

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Life After Martin Shkreli: A Conversation With Turing …

(1 days ago) Then, in June of 2015, he got a fateful call from Martin Shkreli, the CEO of Turing Pharmaceuticals. Shkreli wanted Dr. Salinas to lead his R&D efforts. Salinas was …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


What happened to AIDS drug that spiked 5,000% - CNNMoney

(6 days ago) Imprimis Pharmaceuticals sells this alternative compound for $1 a pill. Turing has said it needs the profits on the drug in order to fund research and …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals Backtracks After 5,000-percent Price …

(7 days ago) Turing Pharmaceuticals CEO Martin Shkreli found himself at the center of a price-gouging scandal this week after he increased the price of popular anti-infective drug Daraprim by more than 5,000

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing

(6 days ago) Product Description. Publication Date: November 08, 2017. Source: Ivey Publishing. Industry: Pharmaceutical industry. In 2015 there was a public outcry over the price increase in Daraprim (pyrimethamine) by Turing Pharmaceuticals AG (Turing). Daraprim was a drug that was widely used by a small population of U.S. patients to treat toxoplasmosis.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


TWKS Stock Forecast, Price & News (Thoughtworks) - MarketBeat

(6 days ago) Their TWKS stock forecasts range from $24.00 to $35.00. On average, they expect Thoughtworks' stock price to reach $29.00 in the next year. This suggests a possible upside of 101.4% from the stock's current price. View analysts' price targets for Thoughtworks or view top-rated stocks among Wall Street analysts.

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals Reviews Glassdoor

(7 days ago) Pros. - great company culture - great benefits - amazing, talented, brilliant people working for the company - flexible hours - everyone wants you to succeed. Cons. - company is losing money - management does not share information with the rest of the company. Continue reading. 1 person found this review helpful. Helpful.

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals AG Announces Development of New Drug …

(4 days ago) Turing Pharmaceuticals AG is a privately-held biopharmaceutical company with offices in Zug Switzerland and New York, NY. Turing focuses on developing and commercializing innovative treatments for

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


6 Salaries at Turing Pharmaceuticals Shared by Employees

(7 days ago) A free inside look at Turing Pharmaceuticals salary trends based on 6 salaries wages for 5 jobs at Turing Pharmaceuticals. Salaries posted anonymously by Turing Pharmaceuticals employees.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Popular Searched

 › Anthem preferred drug list 2022

 › Space coast pharmacy rockledge

 › Urgent care fishers in

 › Iu immediate care carmel

 › Mhs multi health systems

 › Bascom hospital san jose

 › Tamhsc college of pharmacy

 › Rite aid pharmacy job application

 › Va hospital in ga

 › State of mn careers

Recently Searched

 › Home care consultant salary

 › Dean health plan formulary

 › Hospital security risk assessment

 › Hospitals in nj list

 › Different tiers of drugs

 › Drug list for medicare 2021

 › Gateway health plan prior authorization form

 › How does the drug xanax work

 › Ihss provider health benefits

 › Tricare prime vs standard for retirees

FAQ about Turing Pharmaceuticals

What happened to Turing Pharmaceuticals?

3 Turing Pharmaceuticals: a glimpse into controversial drug pricing. Turing Pharmaceuticals: a glimpse into controversial drug pricing. In 2015, an act of greed hidden under the mask of good samaritanism backfired and resulted in the whole planet talking about controversial drug pricing.

Is Turing Pharma a Shkreli?

Feb. 24 —Turing Pharma announces it is officially in business. It acquired three products--an intranasal formulation of ketamine, oxytocin nasal solution, and mecamylamine hydrochloride. The products came from Retrophin, a company Shkreli founded and eventually clashed with.

Is Turing a good stock to buy?

Thoughtworks Holding Inc. is a technology consultancy company which integrates strategy, design and engineering to drive digital innovation. Thoughtworks Holding Inc. is based in CHICAGO. Turing has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 9 buy ratings, 3 hold ratings, and no sell ratings.